1. Home
  2. TECX vs TATT Comparison

TECX vs TATT Comparison

Compare TECX & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.07

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo TAT Technologies Ltd.

TATT

TAT Technologies Ltd.

HOLD

Current Price

$36.90

Market Cap

466.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
TATT
Founded
2019
1985
Country
United States
United States
Employees
60
N/A
Industry
Aerospace
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
466.9M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
TECX
TATT
Price
$29.07
$36.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$75.20
$57.17
AVG Volume (30 Days)
211.4K
156.8K
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.29
Revenue Next Year
N/A
$16.09
P/E Ratio
N/A
$38.61
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$25.52
52 Week High
$35.99
$64.50

Technical Indicators

Market Signals
Indicator
TECX
TATT
Relative Strength Index (RSI) 52.26 49.57
Support Level $27.39 $33.15
Resistance Level $31.17 $41.94
Average True Range (ATR) 1.82 1.66
MACD 0.08 0.69
Stochastic Oscillator 66.98 58.41

Price Performance

Historical Comparison
TECX
TATT

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: